Glioblastoma management in the temozolomide era: have we improved outcome?
about
The role of necroptosis in neurosurgical diseasesPattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factorsBevacizumab in recurrent glioblastoma: five informative patient scenarios.Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.Caudatin Inhibits Human Glioma Cells Growth Through Triggering DNA Damage-Mediated Cell Cycle Arrest.Temozolomide during radiotherapy of glioblastoma multiforme : Daily administration improves survival.WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignantmiR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65.Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.
P2860
Q28083902-80FE37B6-084D-4E9F-9CA8-2AF278ED5F14Q35206264-982E5C5F-556D-4CE8-B3A0-D97531F0BC49Q35545648-CF02EF58-AA9D-4F73-BBC5-1046B88CF728Q38409696-3DA92DD6-0548-4892-9027-1D8D716641A6Q38833453-0FE1560E-87DE-4511-BC68-48394DB62FB6Q38888920-A7C7DA82-3A17-49A4-8D03-99962E32D773Q38961314-B66A79C6-31D2-4E55-B847-10D41BC7C6DCQ38972730-4503DB82-3C48-405F-A916-AEE744B82087Q39020586-143557DC-78D7-431F-9FDA-CFC2DBD581EBQ41093251-E907A317-F40C-4994-A2FA-F4250737B8F4Q41575088-5A2735AE-3CD5-4C6E-9EF7-4F253DA36479Q42795549-02E7428D-AABB-4E7A-84EB-DD6A7C0C8873
P2860
Glioblastoma management in the temozolomide era: have we improved outcome?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Glioblastoma management in the temozolomide era: have we improved outcome?
@en
Glioblastoma management in the temozolomide era: have we improved outcome?
@nl
type
label
Glioblastoma management in the temozolomide era: have we improved outcome?
@en
Glioblastoma management in the temozolomide era: have we improved outcome?
@nl
prefLabel
Glioblastoma management in the temozolomide era: have we improved outcome?
@en
Glioblastoma management in the temozolomide era: have we improved outcome?
@nl
P2093
P2860
P1476
Glioblastoma management in the temozolomide era: have we improved outcome?
@en
P2093
Ahmed Al-Zahrani
Arjun Sahgal
Barbara Ann Miller
Cynthia Menard
Derek MacFadden
Warren P Mason
Zarnie Lwin
P2860
P2888
P304
P356
10.1007/S11060-013-1230-3
P577
2013-08-25T00:00:00Z